Your browser doesn't support javascript.
loading
Three-year follow-up from a phase 3 study of SB3 (a trastuzumab biosimilar) versus reference trastuzumab in the neoadjuvant setting for human epidermal growth factor receptor 2-positive breast cancer.
Pivot, Xavier; Pegram, Mark; Cortes, Javier; Lüftner, Diana; Lyman, Gary H; Curigliano, Giuseppe; Bondarenko, Igor; Yoon, Ye Chan; Kim, Younsoo; Kim, Chul.
Afiliação
  • Pivot X; Paul Strauss Center, Strasbourg, France. Electronic address: xpivot@strasbourg.unicancer.fr.
  • Pegram M; Stanford Comprehensive Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
  • Cortes J; Vall D'Hebron Institute of Oncology (VHIO), Barcelona and Ramon y Cajal University Hospital, Madrid, Spain.
  • Lüftner D; Charité Campus Benjamin Franklin, Humboldt University, Berlin, Germany.
  • Lyman GH; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Curigliano G; IEO, European Institute of Oncology IRCCS, Milano, Italy; University of Milano, Milano, Italy.
  • Bondarenko I; Dnipropetrovsk Medical Academy, Dnipro, Ukraine.
  • Yoon YC; Samsung Bioepis Co., Ltd., Incheon, Republic of Korea.
  • Kim Y; Samsung Bioepis Co., Ltd., Incheon, Republic of Korea.
  • Kim C; Samsung Bioepis Co., Ltd., Incheon, Republic of Korea.
Eur J Cancer ; 120: 1-9, 2019 10.
Article em En | MEDLINE | ID: mdl-31445454
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Carcinoma Lobular / Carcinoma Ductal de Mama / Receptor ErbB-2 / Terapia Neoadjuvante / Medicamentos Biossimilares / Trastuzumab Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Carcinoma Lobular / Carcinoma Ductal de Mama / Receptor ErbB-2 / Terapia Neoadjuvante / Medicamentos Biossimilares / Trastuzumab Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2019 Tipo de documento: Article